NEW YORK (GenomeWeb) – Microbial genetics analysis firm OpGen filed a prospectus on Tuesday for an initial public offering to raise up to about $37 million. 

The Gaithersburg, Md.-based company has not priced its shares yet or said how many shares it plans to offer. It intends to list on the Nasdaq Capital Market under ticker symbol "OPGN." The Maxim Group is listed on OpGen's Form S-1 filed with the US Securities and Exchange Commission as the underwriter for the offering. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.